MedPath

北京金城泰尔制药有限公司

Ownership
-
Established
2003-07-15
Employees
-
Market Cap
-
Website
http://www.jctrzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

28

NMPA:28

Drug Approvals

Posaconazole Enteric-coated Tablets

Product Name
泊沙康唑肠溶片
Approval Number
国药准字H20254332
Approval Date
May 27, 2025
NMPA

Rebamipide Tablets

Product Name
瑞巴派特片
Approval Number
国药准字H20249489
Approval Date
Dec 1, 2024
NMPA

Lornoxicam for Injection

Product Name
注射用氯诺昔康
Approval Number
国药准字H20244283
Approval Date
Jun 28, 2024
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20233658
Approval Date
Jun 7, 2023
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20233659
Approval Date
Jun 7, 2023
NMPA

Nifuratel Capsules

Product Name
硝呋太尔胶囊
Approval Number
国药准字H20094086
Approval Date
Feb 28, 2023
NMPA

Nifuratel Capsules

Product Name
硝呋太尔胶囊
Approval Number
国药准字H20080299
Approval Date
Feb 28, 2023
NMPA

Lornoxicam

Product Name
氯诺昔康
Approval Number
国药准字H20052227
Approval Date
Jul 18, 2022
NMPA

Bisoprolol Fumarate

Product Name
富马酸比索洛尔
Approval Number
国药准字H20057558
Approval Date
Jul 18, 2022
NMPA

Promestriene

Product Name
普罗雌烯
Approval Number
国药准字H20052598
Approval Date
Jul 18, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.